In addition, increased expression of stemness markers OCT4 and SOX2 in Doxorubicin-resistant triple negative breast cancer cells has been observed, supporting the role of these genes in maintaining CSC traits across cancer types [39]. This evidence concerns the gene POU5F1 and triple-negative breast carcinoma.